Cardiovascular & Hematological Disorders-Drug Targets

Formerly Current Drug Targets - Cardiovascular & Hematological Disorders

Editor-in-Chief

Garry X. Shen
University of Manitoba
Winnipeg, MB
(Canada)

Personal Subscription
Become EABM
Become Reviewer
Call for Editor

Articles Ahead of Print

Incidence and Management of Carfilzomib-induced Cardiovascular Toxicity; A Systematic Review and Meta-analysis

Azka Latif *, Vikas Kapoor , Noman Lateef , Muhammad Junaid Ahsan , Rana Mohammad Usman , Saad Ullah Malik , Naqib Ahmad , Nathaniel Rosko , Joslyn Rudoni , Preethi William, Jack Khouri and Faiz Anwer

Is Priapism a Common Presentation of Chronic Myeloid Leukemia in an Adolescent Patient?

Abhishek HL Purohit*, Sujata Sarangi, Deepak Kumar, Gopal K Bohra, Souvik Saha and Himanshu Pandey

Isosteviol Protects H9c2 Cells Against Hypoxia-reoxygenation by Activating ERK1/2

Khaja Shameem Mohammed Abdul, Neha Faiz, Aleksandar Jovanović* and Wen Tan*

Comparison Between the Effects of Bupivacaine and Levobupivacaine for Spinal Anesthesia on QT Dispersion

Veli Fahri Pehlivan*, Murat Akçay, Özlem Cuvaş İkeda and Nermin Göğüş

Prevalence of Congenital Heart Disease among Children in Khorramabad (West of Iran)

Alireza Nezami, Ghobad Heidari, Fariba Tarhani* and Masoumeh Kariminia

Congenital Heart Disease in non-Diabetic Large-for-Gestational-Age (LGA) Neonates

Majid Firouzi, Hamidreza Sherkatolabbasieh*, Alireza Nezami and Shiva Shafizadeh